Published in Science · View the paper (DOI)
The COVID Moonshot Consortium has discovered novel noncovalent and nonpeptidic inhibitors of the SARS-CoV-2 main protease, with promising bioavailability and antiviral activity. The open-science project has yielded a wealth of data on the virus's main protease, paving the way for future therapeutics.
Coverage from 2 institutions